Authors:
KLUMPP TR
GOLDBERG SL
MAGDALINSKI AJ
MANGAN KF
Citation: Tr. Klumpp et al., PHASE-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CARBOPLATIN (CEC) FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL RESCUE IN WOMEN WITH METASTATIC OR HIGH-RISK NONMETASTATIC BREAST-CANCER - MULTIVARIATE-ANALYSIS OF FACTORS AFFECTING SURVIVAL AND ENGRAFTMENT, Bone marrow transplantation, 20(4), 1997, pp. 273-281
Authors:
REDEI I
MANGAN KF
MING PL
MULLANEY MT
RAO PN
GOLDBERG SL
KLUMPP TR
Citation: I. Redei et al., DETECTION OF A DORMANT 20Q- LEUKEMIA CLONE IN BONE-MARROW CULTURES WITH HEMATOPOIETIC GROWTH-FACTORS - IMPLICATIONS FOR SECONDARY LEUKEMIA POSTTRANSPLANT, Bone marrow transplantation, 19(5), 1997, pp. 521-523
Authors:
SHPALL EJ
WHEELER CA
TURNER SA
YANOVICH S
BROWN RA
PECORA AL
SHEA TC
MANGAN KF
WILLIAMS SF
LEMAISTRE CF
LONG GD
MURPHYFILKINS R
PARKER W
GLASPY JA
Citation: Ej. Shpall et al., A RANDOMIZED PHASE-3 STUDY OF PBPC MOBILIZATION BY STEM-CELL FACTOR (SCF, STEMGEN(R)) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER, Blood, 90(10), 1997, pp. 2627-2627
Citation: Tr. Klumpp et al., ASSOCIATION BETWEEN ANTIBODIES REACTIVE WITH NEUTROPHILS, RATE OF NEUTROPHIL ENGRAFTMENT, AND INCIDENCE OF POST-ENGRAFTMENT NEUTROPENIA FOLLOWING BMT, Bone marrow transplantation, 18(3), 1996, pp. 559-564
Authors:
GOLDBERG SL
SHUBERT J
RAO AK
REDEI I
KLUMPP TR
MANGAN KF
Citation: Sl. Goldberg et al., TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH LOW-DOSE TISSUE-PLASMINOGEN ACTIVATOR - IMPACT ON COAGULATION PROFILE, Bone marrow transplantation, 18(3), 1996, pp. 633-636
Authors:
KLUMPP TR
HERMAN JH
INNIS S
PEARLMAN E
CULLING N
KOTZ KW
SLACHTA C
GOLDBERG SL
MANGAN KF
Citation: Tr. Klumpp et al., FACTORS ASSOCIATED WITH RESPONSE TO PLATELET TRANSFUSION FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 17(6), 1996, pp. 1035-1041
Citation: Kf. Mangan et al., RAPID ELIMINATION OF NON-HODGKINS-LYMPHOMA FROM HUMAN BLOOD OR MARROWSTEM-CELLS EMPLOYING IMMUNOMAGNETIC PURGING WITH STREPTAVIDIN COATED FERROFLUIDS, Blood, 88(10), 1996, pp. 1014-1014
Authors:
KLUMPP TR
GOLDBERG SL
MAGDALINSKI AJ
MANGAN KF
Citation: Tr. Klumpp et al., FACTORS AFFECTING THE RATE OF NEUTROPHIL ENGRAFTMENT FOLLOWING HIGH-DOSE THERAPY FOR BREAST-CANCER, Blood, 88(10), 1996, pp. 1191-1191
Authors:
ACKERMAN SJ
KLUMPP TR
HERMAN JH
GUZMAN GI
GOLDBERG SL
MAGDALINSKI AJ
BLEECKER GC
MANGAN KF
Citation: Sj. Ackerman et al., COST-ANALYSIS OF HIGHER-DOSE VERSUS LOWER-DOSE SINGLE-DONOR PLATELET TRANSFUSIONS IN PERIPHERAL-BLOOD STEM-CELL AND BONE-MARROW TRANSPLANT PATIENTS, Blood, 88(10), 1996, pp. 1320-1320
Authors:
GOLDBERG SL
MAGDALINSKI AJ
KLUMPP TR
MANGAN KF
Citation: Sl. Goldberg et al., SURVIVAL OF MARROW TRANSPLANT RECIPIENTS REQUIRING MEDICAL INTENSIVE-CARE UNIT SUPPORT, Blood, 88(10), 1996, pp. 1634-1634
Citation: Tr. Klumpp et al., EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON THE RATE OF NEUTROPHIL ENGRAFTMENT FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Journal of clinical oncology, 13(8), 1995, pp. 2144-2144
Citation: Tr. Klumpp et al., GRANULOCYTE-COLONY-STIMULATING FACTOR ACCELERATES NEUTROPHIL ENGRAFTMENT FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - A PROSPECTIVE, RANDOMIZED TRIAL, Journal of clinical oncology, 13(6), 1995, pp. 1323-1327
Citation: Kf. Mangan, PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - FROM LABORATORY TO CLINICAL-PRACTICE, Seminars in oncology, 22(3), 1995, pp. 202-209
Authors:
KLUMPP TR
HERMAN JH
GOLDBERG SL
MANGAN KF
Citation: Tr. Klumpp et al., AUTOIMMUNE NEUTROPENIA FOLLOWING BONE-MARROW OR BLOOD STEM-CELL TRANSPLANTATION (BMT) - CLINICAL-FEATURES AND RESPONSE TO THERAPY, Blood, 86(10), 1995, pp. 422-422
Authors:
FAY JW
FELSER JM
ABBOUD C
BORSON R
FREYTES C
HERZIG R
HURD D
JANAKIRAMAN N
JANSEN J
LAZARUS H
LYNCH JP
MANGAN KF
SAEZ R
STEVENS DA
WOLFF SN
YANOVICH S
STIFF P
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) THERAPY FOR LYMPHOMA - RESULTS OF A PHASE-III MULTICENTER STUDY, Blood, 86(10), 1995, pp. 875-875
Citation: Sl. Goldberg et al., PACLITAXEL (TAXOL) IN RELAPSED NON-HODGKINS-LYMPHOMA FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3238-3238
Citation: Tj. Reid et al., PURE RED-CELL APLASIA AFTER CHEMOTHERAPY FOR HODGKINS LYMPHOMA - IN-VITRO EVIDENCE FOR T-CELL MEDIATED SUPPRESSION OF ERYTHROPOIESIS AND RESPONSE TO SEQUENTIAL CYCLOSPORINE AND ERYTHROPOIETIN, American journal of hematology, 46(1), 1994, pp. 48-53
Citation: Sl. Goldberg et al., LACK OF A GRAFT-VERSUS-LEUKEMIA EFFECT IN AN IMMUNOLOGICALLY PRIVILEGED SANCTUARY SITE, Bone marrow transplantation, 14(1), 1994, pp. 180-181
Citation: Tr. Klumpp et al., LACK OF TRANSMISSION OF NEUTROPHIL AND PLATELET ANTIBODIES BY INTRAVENOUS IMMUNOGLOBULIN IN BONE-MARROW TRANSPLANT PATIENTS, Transfusion, 34(8), 1994, pp. 677-679